ÂÜÀòÂÒÂ×

Dr. Amogha Tadimety is the Co-Founder and CEO of Nanopath. Amogha is a leader in translational research. Her background combines deep scientific expertise in ultrasensitive biomarker detection with industry experience in life sciences consulting and venture capital.

She earned her Ph.D. from the Thayer School of Engineering at Dartmouth College, NH in 2020 and a B.S.E. in Chemical and Biological Engineering from Princeton University in 2014.